Home » Topics » BioWorld Science

BioWorld Science
RSS

Pivot plans IND filing to begin clinical trials with PVT-005

June 27, 2018

Aclaris initiates phase II trial of ATI-501 for alopecia totalis and alopecia universalis

June 27, 2018

Ensemble Therapeutics divulges IDO-1 inhibitors

June 27, 2018

Fraunhofer-Gesellschaft describes new bacterial glutaminyl cyclase inhibitors

June 27, 2018

Arcus Biosciences, Infinity Pharmaceuticals collaborate on studies of triple combination therapies

June 27, 2018

Apellis initiates phase III trial of APL-2 in PNH

June 27, 2018

Chugai describes OWL-833, an orally active non-peptide GLP-1 receptor agonist

June 27, 2018

In vivo evaluation of PD-L1-targeted PET imaging agent [64Cu]DK222

June 27, 2018

FDA approves Zemdri for cUTI, but issues CRL for bloodstream infections

June 27, 2018

Phase II trial evaluates antimalarial activity of single-dose DSM-265

June 27, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...